T 2036/23 (CNS DELIVERY OF IDURONATE-2-SULFATASE/TAKEDA) of 22.09.2025
- European Case Law Identifier
- ECLI:EP:BA:2025:T203623.20250922
- Date of decision
- 22 September 2025
- Case number
- T 2036/23
- Petition for review of
- -
- Application number
- 19192679.9
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- Methods and compositions for CNS delivery of iduronate-2-sulfatase
- Applicant name
- Takeda Pharmaceutical Company Limited
- Opponent name
- Green Cross Corporation
- Board
- 3.3.04
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 113(2)
- Keywords
- Basis of decision - text or agreement to text withdrawn by patent proprietor
Basis of decision - patent revoked - Catchword
- -
- Cited cases
- T 0073/84
- Citing cases
- -
Order
For these reasons it is decided that:
1. The decision under appeal is set aside.
2. The patent is revoked.